Category REGULATORY

National Hospital

GenSight Biologics and 15–20 National Hospital begin first GS010/LUMEVOQ® treatments under France’s AAC program.

The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ® The 15-20 National Hospital (l’Hôpital national des 15-20) in Paris and GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME…

Read MoreGenSight Biologics and 15–20 National Hospital begin first GS010/LUMEVOQ® treatments under France’s AAC program.
Coya Therapeutics

Coya Therapeutics reports study linking T-cell dysfunction and inflammation in frontotemporal dementia, supporting COYA 302.

Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy Coya Therapeutics, Inc. a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the publication of a…

Read MoreCoya Therapeutics reports study linking T-cell dysfunction and inflammation in frontotemporal dementia, supporting COYA 302.

Veristat Boosts EU Regulatory & Clinical Support for Chinese Pharma and Device Firms

Veristat Expands Regulatory and Clinical Trial Support for Chinese Pharmaceutical and Medical Device Companies Entering Global Markets Veristat, a global contract research organization (CRO) and consulting firm known for its expertise in complex clinical trials, has announced the expansion of…

Read MoreVeristat Boosts EU Regulatory & Clinical Support for Chinese Pharma and Device Firms

Genentech Reports Positive Phase II Results for Petrelintide in Overweight and Obesity

Genentech Reports Positive Phase II Results for Petrelintide, an Amylin Analog for Overweight and Obesity Genentech, a member of the Roche Group today announced positive topline results from the Phase II ZUPREME-1 trial evaluating the investigational drug petrelintide versus placebo…

Read MoreGenentech Reports Positive Phase II Results for Petrelintide in Overweight and Obesity

Missouri Court Approves Preliminary Roundup™ Class Settlement Covering Current and Future Claims

Missouri Court Grants Preliminary Approval for Roundup™ Class Settlement to Address Current and Future Claims A judge in the Circuit Court of the City of St. Louis, Missouri has granted preliminary approval for a proposed class action settlement aimed at…

Read MoreMissouri Court Approves Preliminary Roundup™ Class Settlement Covering Current and Future Claims

Fiber Broadband Association Publishes Paper on Streaming and Gaming Demands

The Fiber Broadband Association (FBA) has released a new thematic paper titled “Fiber is Player #1 for Streaming and Gaming,” examining how streaming, online gaming, and emerging immersive technologies are redefining broadband performance requirements. The report argues that fiber broadband…

Read MoreFiber Broadband Association Publishes Paper on Streaming and Gaming Demands